August 2014 Life Science Industry Research Reports

PharmaPoint: Asthma – Current and Future Players

Published in Aug 2014 ; US $ 2995 Onwards; Publisher: GlobalData

GlobalData has released its pharma report, “PharmaPoint: Asthma Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Asthma Market. The report identifies and analyses the key […]

Dupilumab (Asthma) – Forecast and Market Analysis to 2023

Published in Aug 2014 ; US $ 3495 Onwards; Publisher: GlobalData

GlobalData has released its new PharmaPoint Drug Evaluation report, “Dupilumab (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

Advair (Asthma) – Forecast and Market Analysis to 2023

Published in Aug 2014 ; US $ 3495 Onwards; Publisher: GlobalData

GlobalData has released its new PharmaPoint Drug Evaluation report, “Advair (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

Dulera (Asthma) – Forecast and Market Analysis to 2023

Published in Aug 2014 ; US $ 3495 Onwards; Publisher: GlobalData

GlobalData has released its new PharmaPoint Drug Evaluation report, “Dulera (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

Pulmicort (Asthma) – Forecast and Market Analysis to 2023

Published in Aug 2014 ; US $ 3495 Onwards; Publisher: GlobalData

GlobalData has released its new PharmaPoint Drug Evaluation report, “Pulmicort (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

Spiriva (Asthma) – Forecast and Market Analysis to 2023

Published in Aug 2014 ; US $ 3495 Onwards; Publisher: GlobalData

GlobalData has released its new PharmaPoint Drug Evaluation report, “Spiriva (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

Flutiform (Asthma) – Forecast and Market Analysis to 2023

Published in Aug 2014 ; US $ 3495 Onwards; Publisher: GlobalData

GlobalData has released its new PharmaPoint Drug Evaluation report, “Flutiform (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]